Opdivo

Bristol Myers combo follows Roche, AstraZeneca immunotherapy rivals into first-line liver cancer
Fierce Pharma
Sun, 04/13/25 - 11:19 pm
Bristol Myers Squibb
Opdivo
Yervoy
hepatocellular carcinoma
FDA
Five Biggest Drug Face-Offs in Pharma History
BioSpace
Wed, 04/9/25 - 11:38 am
competition
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Pfizer
Bayer
JNJ
Eliquis
Xarelto
Biogen
Eisai
Eli Lilly
Leqembi
Kisunla
AbbVie
Humira
Stelara
AstraZeneca
Calquence
Imbruvica
FDA Approves Opdivo Plus Yervoy For Some With Colorectal Cancer
Cure Today
Tue, 04/8/25 - 10:49 pm
Bristol Myers Squibb
Opdivo
Yervoy
colorectal cancer
FDA
FDA looks at Opdivo/Yervoy in first-line colorectal cancer
Pharmaphorum
Mon, 02/24/25 - 09:56 am
Bristol Myers Squibb
Opdivo
Yervoy
colorectal cancer
FDA
Keytruda
Merck
Bristol Myers Squibb notches overall survival win with Opdivo in preoperative NSCLC
Fierce Pharma
Thu, 02/20/25 - 11:38 am
Bristol Myers Squibb
Opdivo
non-small cell lung cancer
clinical trials
Bristol Myers, Pfizer tout new standards of care in colorectal cancer subtypes
Fierce Pharma
Sun, 01/26/25 - 04:11 pm
Bristol Myers Squibb
Pfizer
colorectal cancer
Opdivo
Yervoy
Braftovi
FDA approves BMS’ Opdivo Qvantig for solid tumour indications
Yahoo Finance
Mon, 12/30/24 - 11:02 pm
Bristol Myers Squibb
Opdivo Qvantig
Opdivo
FDA
solid tumors
BMS’ Opdivo Bests Pfizer’s Adcetris in Late-Stage Hodgkin’s Lymphoma Study
BioSpace
Thu, 10/17/24 - 09:34 am
Bristol Myers Squibb
Opdivo
Pfizer
Adcetris
clinical trials
Hodgkin's lymphoma
BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval
Fierce Pharma
Thu, 10/3/24 - 10:25 pm
Bristol Myers Squibb
Opdivo
FDA
non-small cell lung cancer
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Wed, 10/2/24 - 11:24 am
FDA
Bridge Bio
acoramidis
AstraZeneca
Daiichi Sankyo
Dato-DXd
Vertex Pharmaceuticals
Vanza Triple
PTC Therapeutics
Upstaza
Bristol Myers Squibb
Opdivo
FDA weighs limiting PD-1 drugs in stomach cancer, calls on experts to discuss Merck, BMS and BeiGene meds
Fierce Pharma
Fri, 08/23/24 - 10:55 am
FDA
stomach cancer
Bristol Myers Squibb
Opdivo
Yervoy
Merck
Keytruda
BeiGene
Tevimbra
BMS eyes April FDA verdict on Opdivo/Yervoy in liver cancer
Pharmaphorum
Thu, 08/22/24 - 11:09 am
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
FDA
Aveo spins a silver lining in failed trial of kidney cancer drug Fotivda
Fierce Pharma
Thu, 07/18/24 - 11:06 pm
Aveo Oncology
kidney cancer
Fotivda
Opdivo
Bristol Myers Squibb
ASCO: With Opdivo-Yervoy combo, Bristol Myers calls Roche and AstraZeneca's bets in first-line liver cancer
Fierce Pharma
Tue, 06/4/24 - 11:52 am
ASCO 2024
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Merck
Eisai
Bayer
Lenvima
Nexavar
Bristol Myers lines up Opdivo treatment in Pakistan, Rwanda and beyond as part of 10-year access campaign
Fierce Pharma
Wed, 05/22/24 - 11:36 am
Bristol Myers Squibb
Opdivo
Pakistan
Rwanda
Zambia
LMICs
FDA Updates PDUFA Date of BLA for Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors
Onc Live
Tue, 05/21/24 - 07:15 pm
FDA
Bristol Myers Squibb
Opdivo
Halozyme
solid tumors
As Bristol Myers reveals trial failure, AstraZeneca's Imfinzi stays king in stage 3 lung cancer
Fierce Pharma
Mon, 05/13/24 - 11:20 am
Bristol Myers Squibb
Opdivo
Yervoy
clinical trials
non-small cell lung cancer
AstraZeneca
Imfinzi
BMS to cut 2,200 jobs in $1.5B restructuring as Opdivo sales drop in Q1
BioSpace
Thu, 04/25/24 - 11:44 am
Bristol Myers Squibb
earnings
Opdivo
layoffs
5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
oncology
clinical trials
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Pfizer
DLBCL
Adcetris
Asieris
HSIL
APL-1702
cervical cancer
Novocure
non-small cell lung cancer
Roche
Genentech
Tecentriq
esophageal squamous cell carcinoma
Padcev, Keytruda, and Balversa leave little room for Opdivo in urothelial carcinoma
Clinical Trials Arena
Thu, 03/21/24 - 06:41 pm
bladder cancer
urothelial cancer
Merck
Pfizer
Bristol Myers Squibb
Padcev
Keytruda
Balversa
Opdivo

Pages